Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
A Double-blind, Randomized, Placebo-controlled Trial of Naloxegol for Prevention of Post-operative Constipation in Spinal Surgery Patients
Sponsor: AstraZeneca
Terminated
Slow recruitment and inability to extend funding.
Other terminated trials from AstraZeneca
Other Constipation trials with similar outcome
A PHASE4 clinical study on Constipation, this trial is terminated or withdrawn. The trial is conducted by AstraZeneca and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Terminated PHASE4
-
Sep 2018 — Oct 2019 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .